GLP-1 Rector Agonists, Androgenetic Alopecia, AI & More | July 8, 2026 | Ep. 83, Issue 113

Join host Raven Lirio and dive sk(in depth) into the latest dermatology research across medical, cosmetic, pediatric, and procedural dermatology.This week’s highlights include:GLP-1 receptor agonist use and clinical outcomes in patients with hidradenitis suppurativaEarly-Onset Androgenetic Alopecia as a Marker of Diabetes RiskArtificial intelligence-based smartphone application for skin cancer detection: a prospective diagnostic accuracy studyTopical steroid withdrawal is a targetable excess of mitochondrial NADMultisystem mucosal morbidity in recessive dystrophic epidermolysis bullosa inversaOnline vs in-person care for atopic dermatitis: A randomized clinical trialMomordin Ic alleviates inflammation and skin barrier dysfunction of atopic dermatitis in vitro and in vivo The rise of the skin bleaching crisis: global perspectives This is a late posting of our July 8th newsletter. All studies discussed are linked above. For questions, comments or future episode suggestions, please email us at [email protected] with sk(in depth):Website: ⁠⁠⁠⁠⁠⁠⁠https://www.skindepthderm.com/subscribe.html⁠⁠⁠⁠⁠⁠⁠Instagram: @skindepthdermX: @skindepth_derm-Music Credits: Tropical Vibe by WinnieTheMoogLink: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/song/10446-tropical-vibe⁠⁠⁠⁠⁠⁠⁠License: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license